Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis.
Saved in:
| Title: | Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis. |
|---|---|
| Authors: | Peng, Shang‐Hsuan1 (AUTHOR), Lin, Ching‐Hung2 (AUTHOR), Chen, I‐Chun2 (AUTHOR), Shen, Ying‐Chun2 (AUTHOR), Chang, Dwan‐Ying3 (AUTHOR), Chen, Tom Wei‐Wu3 (AUTHOR), Huang, Shu‐Min3 (AUTHOR), Hu, Fu‐Chang4,5 (AUTHOR), Lu, Yen‐Shen3 (AUTHOR) yslu@ntu.edu.tw |
| Source: | Cancer Medicine. Oct2023, Vol. 12 Issue 19, p20035-20051. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
